Maddalena Napolitano

InstitutionUniversity of Molise
AddressCampobasso
Italy
vCardDownload vCard
    Publication Timeline
    COVID-19 publications
    Bar chart showing 16 Covid-19 publications, with a maximum of 4 publications in May 2020
    All Publications
    Bar chart showing 97 publications over 22 distinct years, with a maximum of 18 publications in 2018
    These graphs show COVID-19 publications by month since August 2019 and all publications written by authors of COVID-19 publications over the past 30 years.

    To see the data from both graphs as text, click here.
    Publication Field Summary
    This graph shows the number and percent of publications by field. Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications. Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written. To see the data as text, click here.
    Publication List
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications.
    Sort By:     Newest   |   Oldest   |   Most Cited   |   Most Discussed
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Passante M, Napolitano M, Dastoli S, Bennardo L, Fabbrocini G, Nisticò SP, Patruno C. Safety of omalizumab treatment in patients with chronic spontaneous urticaria and COVID-19. Dermatol Ther. 2021 11; 34(6):e15111. PMID: 34427028.
      Citations: 3     Fields:    Translation:Humans
    2. Hansel K, Patruno C, Antonelli E, Dal Bello G, Napolitano M, Fabbrocini G, Grieco T, Pellacani G, Fargnoli MC, Esposito M, Piras V, Zucca M, Girolomoni G, Stingeni L. Dupilumab in adolescents with moderate to severe atopic dermatitis: a 32-week real-world experience during the COVID-19 pandemic. Clin Exp Dermatol. 2022 01; 47(1):165-167. PMID: 34309892.
      Citations: 3     Fields:    Translation:Humans
    3. Bennardo L, Nisticò SP, Dastoli S, Provenzano E, Napolitano M, Silvestri M, Passante M, Patruno C. Erythema Multiforme and COVID-19: What Do We Know? Medicina (Kaunas). 2021 Aug 16; 57(8). PMID: 34441034.
      Citations: 2     Fields:    Translation:Humans
    4. Stingeni L, Hansel K, Antonelli E, Bello GD, Patruno C, Napolitano M, Fabbrocini G, Grieco T, Pellacani G, Fargnoli MC, Esposito M, Piras V, Zucca M, Girolomoni G. Atopic dermatitis in adolescents: Effectiveness and safety of dupilumab in a 16-week real-life experience during the COVID-19 pandemic in Italy. Dermatol Ther. 2021 09; 34(5):e15035. PMID: 34152670.
      Citations: 1     Fields:    Translation:HumansPHPublic Health
    5. Patruno C, Napolitano M, Stingeni L, Fabbrocini G. Skin rashes after SARS-CoV-2 vaccine: which relationship, if any? Immun Inflamm Dis. 2021 09; 9(3):622-623. PMID: 34145775.
      Citations: 1     Fields:    Translation:Humans
    6. Stingeni L, Bianchi L, Zalaudek I, Pigatto PD, Peris K, Patruno C, Fabbrocini G, Micali G, Napolitano M, Tramontana M, Hansel K. Adverse cutaneous and mucous reactions from anti SARS-CoV-2 vaccines: recommendations from the Italian Society of Dermatology (SIDeMaST). Ital J Dermatol Venerol. 2021 Apr; 156(2):115-117. PMID: 33960747.
      Citations:    Translation:Humans
    7. Annunziata MC, Megna M, Napolitano M, Cacciapuoti S, Marasca C, Fabbrocini G. Coronavirus disease and dermatology: current and future challenges. G Ital Dermatol Venereol. 2020 Oct; 155(5):683-684. PMID: 33070572.
      Citations:    Fields:    Translation:HumansPHPublic Health
    8. Napolitano M, Patruno C, Ruggiero A, Nocerino M, Fabbrocini G. Safety of dupilumab in atopic patients during COVID-19 outbreak. J Dermatolog Treat. 2022 Feb; 33(1):600-601. PMID: 32419563.
      Citations: 4     Fields:    
    9. Megna M, Napolitano M, Patruno C, Fabbrocini G. Biologics for psoriasis in COVID-19 era: What do we know? Dermatol Ther. 2020 07; 33(4):e13467. PMID: 32338424.
      Citations: 9     Fields:    Translation:HumansCellsPHPublic Health
    10. Patruno C, Nisticò SP, Fabbrocini G, Napolitano M. Is climate change the next pandemic for dermatology? Lessons from COVID-19. Dermatol Ther. 2020 Jul; 33(4):e13682. PMID: 32447805.
      Citations:    Fields:    Translation:HumansCellsPHPublic Health
    11. Patruno C, Fabbrocini G, Stingeni L, Napolitano M. The role of occupational dermatology in the COVID-19 outbreak. Contact Dermatitis. 2020 08; 83(2):174-175. PMID: 32319103.
      Citations: 4     Fields:    Translation:HumansCellsPHPublic Health
    12. Patruno C, Stingeni L, Fabbrocini G, Hansel K, Napolitano M. Dupilumab and COVID-19: What should we expect? Dermatol Ther. 2020 Jul; 33(4):e13502. PMID: 32362061.
      Citations: 10     Fields:    Translation:HumansCellsPHPublic Health
    13. Patruno C, Nisticò SP, Fabbrocini G, Napolitano M. COVID-19, quarantine, and atopic dermatitis. Med Hypotheses. 2020 10; 143:109852. PMID: 32447099.
      Citations: 4     Fields:    Translation:HumansCellsPHPublic Health
    14. Marasca C, Ruggiero A, Napolitano M, Fabbrocini G, Megna M. May COVID-19 outbreaks lead to a worsening of skin chronic inflammatory conditions? Med Hypotheses. 2020 Oct; 143:109853. PMID: 32492559.
      Citations: 5     Fields:    Translation:HumansCellsPHPublic Health
    15. Napolitano M, Fabbrocini G, Patruno C. Reply: Potential role of Janus kinase inhibitors in COVID-19. J Am Acad Dermatol. 2020 07; 83(1):e65. PMID: 32339701.
      Citations: 6     Fields:    Translation:HumansCellsPHPublic Health
    16. Megna M, Napolitano M, Fabbrocini G. May IL-17 have a role in COVID-19 infection? Med Hypotheses. 2020 07; 140:109749. PMID: 32339777.
      Citations: 17     Fields:    Translation:HumansAnimalsCellsPHPublic Health
    Napolitano's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (188)
    Explore
    _
    Co-Authors (42)
    Explore
    _
    Similar People (60)
    Explore
    _